Compare MESO & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | NRDS |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 631.6M |
| IPO Year | 2005 | 2021 |
| Metric | MESO | NRDS |
|---|---|---|
| Price | $15.12 | $9.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 171.5K | ★ 574.3K |
| Earning Date | 02-26-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.42 |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $836,600,000.00 |
| Revenue This Year | $629.74 | $10.13 |
| Revenue Next Year | $30.65 | $7.11 |
| P/E Ratio | ★ N/A | $24.92 |
| Revenue Growth | N/A | ★ 21.67 |
| 52 Week Low | $13.05 | $7.33 |
| 52 Week High | $21.50 | $16.24 |
| Indicator | MESO | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 38.64 |
| Support Level | $14.16 | $9.07 |
| Resistance Level | $16.06 | $9.75 |
| Average True Range (ATR) | 0.37 | 0.25 |
| MACD | -0.26 | -0.08 |
| Stochastic Oscillator | 25.95 | 8.78 |
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.